News | June 08, 2026
Roche signs up to $2.3 billion deal with Nurix for BTK degrader Bexobrutideg
The agreement underscores Roche’s commitment to advancing innovative therapies for blood cancers and other serious diseases
The agreement underscores Roche’s commitment to advancing innovative therapies for blood cancers and other serious diseases
The webinar on World Environment Day brought together scientists, policymakers, industry representatives, and researchers to discuss the role of biotech and biomanufacturing in addressing climate change and advancing sustainable development
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
At the center of the project is a new cosmetics line developed through collaboration between industry and medicine
The collaboration introduces a flexible, end-to-end CDx framework designed to adapt to shifting regulatory environments
The safety profile was described as manageable, though not without notable toxicities
The therapy also delivered significant improvements in key liver enzyme markers
The findings mark one of the longest progression-free survival outcomes ever reported in advanced lung cancer
The programme evaluated anselamimab as a first-line add-on to standard plasma cell dyscrasia therapy in patients with advanced cardiac AL amyloidosis
Solvay will fund Pantys-led initiatives targeting vulnerable communities through product donations and menstrual health education programs
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
